186 related articles for article (PubMed ID: 17582678)
21. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
[TBL] [Abstract][Full Text] [Related]
22. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
[TBL] [Abstract][Full Text] [Related]
23. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
24. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
25. The analysis for identifying large DNA fragment aberrations of MSH2 and MLH1 genes from familial colorectal cancer in China.
Zhu M; Liu XR; Huang YQ; Yuan Y; Li JT; Zhang XM; Zhang YY; Wang YP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):603-6. PubMed ID: 16331552
[TBL] [Abstract][Full Text] [Related]
26. A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations.
Martínez-Bouzas C; Beristain E; Ojembarrena E; Errasti J; Mujika K; Viguera N; Tejada MI
Fam Cancer; 2009; 8(4):533-9. PubMed ID: 19760518
[TBL] [Abstract][Full Text] [Related]
27. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
[TBL] [Abstract][Full Text] [Related]
28. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
[TBL] [Abstract][Full Text] [Related]
29. Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction.
Vaughn CP; Lyon E; Samowitz WS
J Mol Diagn; 2008 Jul; 10(4):355-60. PubMed ID: 18556772
[TBL] [Abstract][Full Text] [Related]
30. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families.
Grabowski M; Mueller-Koch Y; Grasbon-Frodl E; Koehler U; Keller G; Vogelsang H; Dietmaier W; Kopp R; Siebers U; Schmitt W; Neitzel B; Gruber M; Doerner C; Kerker B; Ruemmele P; Henke G; Holinski-Feder E
Genet Test; 2005; 9(2):138-46. PubMed ID: 15943554
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.
Aissi-Ben Moussa S; Moussa A; Lovecchio T; Kourda N; Najjar T; Ben Jilani S; El Gaaied A; Porchet N; Manai M; Buisine MP
Fam Cancer; 2009; 8(2):119-26. PubMed ID: 18792805
[TBL] [Abstract][Full Text] [Related]
32. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC).
Li L; McVety S; Younan R; Liang P; Du Sart D; Gordon PH; Hutter P; Hogervorst FB; Chong G; Foulkes WD
Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541406
[TBL] [Abstract][Full Text] [Related]
33. Hereditary nonpolyposis colorectal cancer in endometrial cancer patients.
Yoon SN; Ku JL; Shin YK; Kim KH; Choi JS; Jang EJ; Park HC; Kim DW; Kim MA; Kim WH; Lee TS; Kim JW; Park NH; Song YS; Kang SB; Lee HP; Jeong SY; Park JG
Int J Cancer; 2008 Mar; 122(5):1077-81. PubMed ID: 17973265
[TBL] [Abstract][Full Text] [Related]
34. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
Kovacs ME; Papp J; Szentirmay Z; Otto S; Olah E
Hum Mutat; 2009 Feb; 30(2):197-203. PubMed ID: 19177550
[TBL] [Abstract][Full Text] [Related]
35. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
[TBL] [Abstract][Full Text] [Related]
36. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes.
Woods MO; Hyde AJ; Curtis FK; Stuckless S; Green JS; Pollett AF; Robb JD; Green RC; Croitoru ME; Careen A; Chaulk JA; Jegathesan J; McLaughlin JR; Gallinger SS; Younghusband HB; Bapat BV; Parfrey PS
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6853-61. PubMed ID: 16203774
[TBL] [Abstract][Full Text] [Related]
37. Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.
Tang R; Hsiung C; Wang JY; Lai CH; Chien HT; Chiu LL; Liu CT; Chen HH; Wang HM; Chen SX; Hsieh LL;
Clin Genet; 2009 Apr; 75(4):334-45. PubMed ID: 19419416
[TBL] [Abstract][Full Text] [Related]
38. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
[TBL] [Abstract][Full Text] [Related]
39. [Large genomic deletions of mismatch repair genes in Chinese patients with hereditary nonpolyposis colorectal cancer].
Haung YQ; Yuan Y; Wang YP; Zhu M; Zhang SZ; Zheng S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):88-90. PubMed ID: 15696491
[TBL] [Abstract][Full Text] [Related]
40. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
